Literature DB >> 16412625

Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients.

Ewoudt M W van de Garde1, Patrick C Souverein, Jules M M van den Bosch, Vera H M Deneer, Wim G Goettsch, Hubert G M Leufkens.   

Abstract

STUDY
OBJECTIVES: To assess whether prior outpatient treatment is associated with outcome in patients hospitalized for community-acquired pneumonia (CAP). PATIENTS AND METHODS: All patients with a first hospital admission for CAP between 1995 and 2000 were selected. Patients were divided into two groups, one of patients with use of antibacterial agents prior to hospitalization and one of patients treated as inpatient directly. The main outcome measures were duration of hospital stay and in-hospital mortality.
RESULTS: The two patient groups comprised 296 and 794 patients, respectively. The median duration of hospital stay was 10 days and was similar for both groups. In patients with respiratory diseases or heart failure, the median duration of hospital stay was 12 and 14 days, respectively. The overall in-hospital mortality was 7.2% and did not largely differ between both groups. In patients with congestive heart failure, the mortality was 9.8% for controls and 23.3% for patients hospitalized after initial outpatient treatment (adjusted OR 2.78, 95% CI 1.01-7.81).
CONCLUSIONS: Prior outpatient antibacterial therapy is not associated with outcome in hospitalized pneumonia patients. In patients with underlying chronic heart failure, prior outpatient antibiotic is associated with a significant increased mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412625     DOI: 10.1016/j.rmed.2005.11.024

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study.

Authors:  Ewoudt M W van de Garde; Henrik Endeman; Remco N van Hemert; G Paul Voorn; Vera H M Deneer; Hubert G M Leufkens; Jules M M van den Bosch; Douwe H Biesma
Journal:  Eur J Clin Pharmacol       Date:  2007-11-30       Impact factor: 2.953

2.  The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study.

Authors:  Biswajit Chakrabarti; Dan Wootton; Steven Lane; Elizabeth Kanwar; Joseph Somers; Jacyln Proctor; Nancy Prospero; Mark Woodhead
Journal:  Pneumonia (Nathan)       Date:  2018-03-25

3.  Tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia: an analysis of risk factors.

Authors:  Nathalie Dartois; C Angel Cooper; Nathalie Castaing; Hassan Gandjini; Denise Sarkozy
Journal:  Open Respir Med J       Date:  2013-02-22

4.  Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study.

Authors:  Eric M Mortensen; Marcos I Restrepo; Jacqueline A Pugh; Antonio Anzueto
Journal:  BMC Res Notes       Date:  2008-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.